Based on the above research background, this study used radical radiotherapy using lobaplatin treatment III - IV stage B nasopharyngeal carcinoma, understanding of lobaplatin in locally advanced nasopharyngeal carcinoma radiotherapy concurrent application dose tolerance and dose limiting toxicity, and provide clinical basis for further research.